# Impact of Beta Blockers on TAVI (BETA-TAVI)

> **NCT05721170** · PHASE4 · RECRUITING · sponsor: **National and Kapodistrian University of Athens** · enrollment: 347 (estimated)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DRUG:** Beta blocker

## Key facts

- **NCT ID:** NCT05721170
- **Lead sponsor:** National and Kapodistrian University of Athens
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2028-01-30
- **Final completion:** 2028-01-31
- **Target enrollment:** 347 (ESTIMATED)
- **Last updated:** 2024-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05721170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05721170, "Impact of Beta Blockers on TAVI (BETA-TAVI)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05721170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*